We are excited to announce that the repository will soon undergo an upgrade, featuring a new look and feel along with several enhanced features to improve your experience. Please be on the lookout for further updates and announcements regarding the launch date. We appreciate your support and look forward to unveiling the improved platform soon.
dc.contributor.author | Peirano, Gisele![]() |
|
dc.contributor.author | Chen, Liang![]() |
|
dc.contributor.author | Nobrega, Diego![]() |
|
dc.contributor.author | Finn, Thomas J.![]() |
|
dc.date.accessioned | 2023-06-08T05:12:28Z | |
dc.date.available | 2023-06-08T05:12:28Z | |
dc.date.issued | 2022-05 | |
dc.description.abstract | We describe the global molecular epidemiology of 229 carbapenemase-producing Escherichia coli in 36 countries during 2015–2017. Common carbapenemases were oxacillinase (OXA) 181 (23%), New Delhi metallo-β-lactamase (NDM) 5 (20%), OXA-48 (17%), Klebsiella pneumoniae carbapenemase 2 (15%), and NDM-1 (10%). We identified 5 dominant sequence types (STs); 4 were global (ST410, ST131, ST167, and ST405), and 1 (ST1284) was limited to Turkey. OXA-181 was frequent in Jordan (because of the ST410-B4/H24RxC subclade) and Turkey (because of ST1284). We found nearly identical IncX3-blaOXA-181 plasmids among 11 STs from 12 countries. NDM-5 was frequent in Egypt, Thailand (linked with ST410-B4/H24RxC and ST167-B subclades), and Vietnam (because of ST448). OXA-48 was common in Turkey (linked with ST11260). Global K. pneumoniae carbapenemases were linked with ST131 C1/H30 subclade and NDM-1 with various STs. The global carbapenemase E. coli population is dominated by diverse STs with different characteristics and varied geographic distributions, requiring ongoing genomic surveillance. | en_US |
dc.description.department | Medical Microbiology | en_US |
dc.description.librarian | am2023 | en_US |
dc.description.sponsorship | The Joint Programming Initiative on Antimicrobial Resistance–Canadian Institute Health Research program and the US National Institutes of Health. | en_US |
dc.description.uri | http://wwwnc.cdc.gov/eid | en_US |
dc.identifier.citation | Peirano, G., Chen, L., Nobrega, D. et al. 2022, 'Genomic epidemiology of global carbapenemase-producing escherichia coli, 2015–2017', Emerging Infectious Diseases, vol. 28, no. 5, pp. 924-931, doi : 10.3201/eid2805.212535. . | en_US |
dc.identifier.issn | 1080-6040 (print) | |
dc.identifier.issn | 1080-6059 (online) | |
dc.identifier.other | 10.3201/eid2805.212535 | |
dc.identifier.uri | http://hdl.handle.net/2263/91048 | |
dc.language.iso | en | en_US |
dc.publisher | Centers for Disease Control and Prevention | en_US |
dc.rights | © 2022, Centers for Disease Control and Prevention (CDC). All rights reserved. | en_US |
dc.subject | Surveillance | en_US |
dc.subject | Carbapenemases | en_US |
dc.subject | Molecular epidemiology | en_US |
dc.subject | Escherichia coli | en_US |
dc.subject | Bacteria | en_US |
dc.subject | Whole-genome sequencing (WGS) | en_US |
dc.subject | Antimicrobial resistance (AMR) | en_US |
dc.title | Genomic epidemiology of global carbapenemase-producing Escherichia coli, 2015–2017 | en_US |
dc.type | Article | en_US |